Skip to content
Billionaire Profile
Cen Junda
Global Rank
#733

Cen Junda

CEO, Pharmaceuticals
Lianyungang, China
Real-Time Net Worth
$5.78B
Estimated based on Pharmaceuticals stock value as of September 10, 2026
-4.81% (24h)
Age
61
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
China

Biography

Cen Junda is a prominent figure in the Chinese pharmaceutical industry, renowned for his strategic investments and significant wealth. His estimated net worth, as of March 24, 2026, is $6.6 Billion. Cen Junda's fortune is primarily derived from his substantial stakes in Jiangsu Hengrui Pharmaceuticals and Hansoh Pharmaceutical Group, both key players in China's healthcare sector. His career is marked by a deep understanding of the pharmaceutical industry, which he leveraged to identify and support promising ventures. Cen Junda's influence extends beyond personal wealth, contributing to the growth and innovation within China's biopharma market.

AI-Assisted Draft
Not yet reviewed by an editor — how we work
Data Updated
Sep 10, 2026
Report a Correction

Wealth Over Time

Net Worth History

YearNet Worth
2026$5.78B
2025$7.30B
2024$7.00B
2021$11.6B
2020$10.5B

Portfolio Holdings

Hansoh Pharmaceutical Group

Hansoh Pharmaceutical Group

3692.HKFood Beverage
Lianyungang, China
8000+ employees
Founded 1995
Jiangsu Hengrui Pharmaceuticals

Jiangsu Hengrui Pharmaceuticals

healthcare

In-Depth Profile

Early Life and Education

Cen Junda's early life and background are not widely detailed in public sources. However, it's known that he holds degrees from Zhejiang University and the China State Institute of Pharmaceutical Industry. This educational foundation provided him with the technical expertise to understand the pharmaceutical sector deeply.

Rise to Success

Cen Junda's rise to prominence is directly linked to his strategic investments in the pharmaceutical industry. He recognized the potential of companies like Jiangsu Hengrui Medicine and Hansoh Pharmaceutical Group early on. His investments proved highly lucrative as these companies grew and innovated in the market. His financial success is tied to the massive appreciation of his equity in these companies following their successful commercialization of innovative drugs.

Key Business Strategies

Cen Junda's key business strategy revolves around identifying and investing in high-potential pharmaceutical companies. He appears to focus on companies with strong research and development capabilities, especially in areas like oncology and metabolic diseases. His investment approach aligns with the long-term growth of the companies he backs.

Philanthropy

There is no readily available information about Cen Junda's philanthropic activities.

Career Milestones

1990

Investment in Jiangsu Hengrui Medicine

Made a strategic investment in Jiangsu Hengrui Medicine, contributing to the company's growth as a major pharmaceutical player.

1995

Investment in Hansoh Pharmaceutical Group

Made a strategic investment in Hansoh Pharmaceutical Group, contributing to the company's growth as a major pharmaceutical player.

Billionaires Connected to Cen Junda

Peers in Healthcare

All Healthcare billionaires

Richest in China

All billionaires from China

Adjacent Global Ranks

Full global ranking

Frequently Asked Questions

What is Cen Junda's net worth in 2026?
As of 2026, Cen Junda's estimated net worth is $5.777 billion, ranking #733 among the world's billionaires. The estimate is based on publicly available shareholding data and market prices, updated daily.
How did Cen Junda make their money?
Cen Junda's wealth primarily comes from Pharmaceuticals, most notably through Pharmaceuticals.
Where is Cen Junda from?
Cen Junda is from China.
How old is Cen Junda?
Cen Junda is 61 years old.

Sources & References

  1. Cen Junda — Forbes profile Forbes